Prescient Therapeutics Ltd has released a press release.
Appendix 4E and 2020 Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
Story so far
Earlier from Prescient Therapeutics
- Successful SPP Closed Early
- Extension of Share Purchase Plan
- PTX Announces Cell Therapy Collaboration with Peter Mac
- PTX-100 progresses to next cohort in basket clinical study
- PTX-200 AML Trial Progresses to Next Dose Level
Later from Prescient Therapeutics
- PTX Raises $7 million via Strongly Supported Placement
- Response to ASX Query
- September 2020 Quarterly Update and Appendix 4C
- Prescient Receives $1.03m R&D Tax Rebate
- PTX announces 3 next-gen CAR-T programs with OmniCAR
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics